INGRAM ROBERT ALEXANDER
Insider CIK 1219890 · EW Director · PHAS 10% owner · NOVN Director · CLSD 10% owner · GTHX 10% owner · BDTX Director · AGN Director · REGN Director · BCRX Director · VRX Director · CREE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-02-28 | 2023-03-02 | 2,259 | $8.85 | $20.0K | 100,198 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-12-16 | 2022-12-19 | 9,375 | $1.50 | $14.1K | 42,854 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-11-30 | 2022-12-02 | 1,497 | $13.36 | $20.0K | 97,939 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-09-16 | 2022-09-19 | 6,584 | $2.62 | $17.3K | 33,479 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-08-31 | 2022-09-02 | 1,438 | $13.90 | $20.0K | 96,442 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-06-17 | 2022-06-17 | 8,498 | $2.03 | $17.3K | 26,895 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 95,004 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-05-31 | 2022-06-02 | 2,078 | $9.31 | $19.3K | 82,138 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-03-18 | 2022-03-18 | 5,795 | $3.02 | $17.5K | 18,397 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-02-28 | 2022-03-02 | 1,128 | $16.61 | $18.7K | 80,060 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-12-17 | 2021-12-17 | 3,296 | $5.31 | $17.5K | 12,602 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-11-30 | 2021-12-02 | 1,554 | $12.06 | $18.7K | 78,932 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-09-17 | 2021-09-23 | 1,869 | $9.90 | $18.5K | 9,306 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-08-31 | 2021-09-02 | 1,177 | $15.92 | $18.7K | 77,378 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-06-18 | 2021-06-22 | 1,255 | $12.95 | $16.3K | 7,437 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-05-28 | 2021-06-01 | 1,188 | $15.77 | $18.7K | 76,201 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-05-25 | 2021-05-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-03-18 | 2021-03-22 | 677 | $24.01 | $16.3K | 6,182 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-02-26 | 2021-03-02 | 1,739 | $10.78 | $18.7K | 75,013 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2020-12-15 | 2020-12-16 | 505 | $34.29 | $17.3K | 5,505 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-11-30 | 2020-12-02 | 3,669 | $5.11 | $18.7K | 73,274 | SEC↗ |
| BDTX Black Diamond Therapeutics | P Buy | 2020-09-30 | 2020-10-01 | 5,000 | $30.46 | $152.3K | 5,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2020-09-25 | 2020-09-29 | 29,842 | — | $0 | 29,842 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-08-31 | 2020-09-02 | 4,518 | $4.15 | $18.7K | 69,605 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2020-07-28 | 2020-07-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-06-01 | 2020-06-03 | 4,171 | $4.50 | $18.8K | 65,087 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-03-01 | 2020-03-03 | 6,250 | $3.00 | $18.8K | 60,916 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-12-01 | 2019-12-03 | 6,578 | $2.85 | $18.7K | 54,666 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 20,000 | $1.45 | $29.0K | 48,088 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-09-01 | 2019-09-04 | 6,270 | $2.99 | $18.7K | 28,088 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2019-07-31 | 2019-08-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-05-29 | 2019-05-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NOVN Novan, Inc. | P Buy | 2019-05-22 | 2019-05-23 | 50,000 | $2.21 | $110.5K | 169,777 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 994 | $5.00 | $5.0K | 40,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | $0.12 | $5.0K | 41,414 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 104 | $5.00 | $520 | 13,558 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | $0.12 | $517 | 13,662 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,139 | $5.00 | $5.7K | 149,320 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | $0.12 | $5.7K | 150,459 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 42 | $5.00 | $210 | 94,874 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | $0.12 | $208 | 94,916 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 458 | $5.00 | $2.3K | 1,044,764 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | $0.12 | $2.3K | 1,045,222 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 42,530 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,862 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 174,699 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,609 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,044,764 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 94,874 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 149,320 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,558 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 40,420 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 272,107 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 24,709 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 226,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 4,846 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 12,487 | $5.00 | $62.4K | 163,099 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 150,612 | — | $0 | 150,612 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 137,513 | $5.00 | $687.6K | 1,820,933 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 266,481 | — | $0 | 266,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 52,690 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 150,000 | $5.00 | $750.0K | 416,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 1,683,420 | — | $0 | 1,683,420 | SEC↗ |
| CREE CREE INC | A Award | 2018-10-17 | 2018-10-18 | 760 | $39.46 | $30.0K | 77,710 | SEC↗ |
| NOVN Novan, Inc. | P Buy | 2018-09-28 | 2018-10-01 | 50,000 | $2.84 | $142.0K | 119,777 | SEC↗ |
| CREE CREE INC | M Exercise deriv | 2018-08-30 | 2018-08-31 | 4,000 | $30.92 | $123.7K | 0 | SEC↗ |
| CREE CREE INC | M Exercise | 2018-08-30 | 2018-08-31 | 4,000 | $30.92 | $123.7K | 76,950 | SEC↗ |
| CREE CREE INC | A Award | 2018-08-15 | 2018-08-16 | 648 | $46.26 | $30.0K | 72,950 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-06-20 | 2018-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2018-06-04 | 2018-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2018-06-01 | 2018-06-04 | 2,916 | $6.43 | $18.7K | 21,818 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 41,710 | $48.00 | $2.00M | 3,237,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 758,290 | $48.00 | $36.40M | 3,279,421 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 474 | $50.50 | $23.9K | 4,037,737 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 26 | $50.50 | $1.3K | 4,037,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 5,592 | $50.86 | $284.4K | 4,038,519 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 308 | $50.69 | $15.6K | 4,038,211 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 474 | $52.13 | $24.7K | 4,044,137 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 26 | $52.13 | $1.4K | 4,044,111 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 1,595 | $51.06 | $81.4K | 4,044,611 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 29,005 | $51.16 | $1.48M | 4,046,206 | SEC↗ |
| CREE CREE INC | A Award | 2018-04-25 | 2018-04-27 | 764 | $39.25 | $30.0K | 72,302 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2018-03-01 | 2018-03-02 | 3,772 | $4.97 | $18.7K | 18,902 | SEC↗ |
| CREE CREE INC | A Award | 2018-01-24 | 2018-01-26 | 833 | $35.98 | $30.0K | 71,538 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-12-01 | 2017-12-04 | 3,690 | $5.08 | $18.7K | 15,130 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 99,513 | — | $0 | 4,074,216 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 995 | — | $0 | 4,075,211 | SEC↗ |
| CREE CREE INC | A Award | 2017-10-18 | 2017-10-20 | 731 | $34.16 | $25.0K | 70,705 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-09-01 | 2017-09-05 | 3,676 | $5.10 | $18.7K | 11,440 | SEC↗ |
| CREE CREE INC | A Award | 2017-09-01 | 2017-09-06 | 7,033 | — | $0 | 69,974 | SEC↗ |
| NOVN Novan, Inc. | P Buy | 2017-08-29 | 2017-08-29 | 8,465 | $4.70 | $39.8K | 69,777 | SEC↗ |
| NOVN Novan, Inc. | P Buy | 2017-08-25 | 2017-08-29 | 3,535 | $4.25 | $15.0K | 61,312 | SEC↗ |
| CREE CREE INC | A Award | 2017-08-23 | 2017-08-24 | 1,125 | $22.21 | $25.0K | 62,941 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2017-06-05 | 2017-06-07 | 34,014 | — | $0 | 34,014 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-06-01 | 2017-06-02 | 1,941 | $5.15 | $10.0K | 7,764 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 6,568,527 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,009,693 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 2,584,959 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,318,681 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 212,419 | — | $0 | 212,419 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 3,728,464 | — | $0 | 3,728,464 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-22 | 2017-05-24 | 133,333 | $15.00 | $2.00M | 3,861,797 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 99,513 | — | $0 | 99,513 | SEC↗ |
| CREE CREE INC | A Award | 2017-04-26 | 2017-04-27 | 1,132 | $22.07 | $25.0K | 61,816 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2017-03-31 | 2017-04-04 | 2,120 | $11.03 | $23.4K | 92,046 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-03-02 | 2017-03-02 | 1,602 | $6.24 | $10.0K | 5,823 | SEC↗ |
| CREE CREE INC | A Award | 2017-01-25 | 2017-01-26 | 867 | $28.83 | $25.0K | 60,684 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 6,478 | $8.22 | $53.2K | 1,757,719 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 7,592 | $8.22 | $62.4K | 2,060,514 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 10,457 | $8.64 | $90.3K | 1,764,197 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 12,258 | $8.64 | $105.9K | 2,068,106 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 8,366 | $8.92 | $74.6K | 1,774,654 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 9,806 | $8.92 | $87.5K | 2,080,364 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-12-30 | 2017-01-04 | 1,463 | $14.52 | $21.2K | 89,926 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-12-01 | 2016-12-02 | 1,788 | $5.59 | $10.0K | 4,221 | SEC↗ |
| CREE CREE INC | A Award | 2016-10-19 | 2016-10-20 | 1,115 | $22.41 | $25.0K | 59,817 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-09-30 | 2016-10-05 | 865 | $24.55 | $21.2K | 88,463 | SEC↗ |
| NOVN Novan, Inc. | C Conversion deriv | 2016-09-26 | 2016-09-28 | 27,777 | — | $0 | 0 | SEC↗ |
| NOVN Novan, Inc. | C Conversion | 2016-09-26 | 2016-09-28 | 27,777 | — | $0 | 57,777 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2016-09-20 | 2016-09-22 | 14,484 | — | $0 | 14,484 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-09-01 | 2016-09-06 | 2,433 | $4.11 | $10.0K | 2,433 | SEC↗ |
| CREE CREE INC | A Award | 2016-09-01 | 2016-09-06 | 6,429 | — | $0 | 58,702 | SEC↗ |
| CREE CREE INC | A Award | 2016-08-17 | 2016-08-18 | 1,229 | $23.38 | $28.7K | 52,273 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-06-30 | 2016-07-11 | 1,080 | $20.14 | $21.8K | 87,598 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-06-17 | 2016-06-21 | 16,726 | — | $0 | 86,518 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,897 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,908 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,941 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,898 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,940 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,907 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,223 | — | $0 | 1,654,248 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 414,286 | $7.00 | $2.90M | 2,090,170 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,953 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,884 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 107,142 | $7.00 | $750.0K | 1,783,020 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,878 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,947 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,219 | — | $0 | 1,654,242 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-05-02 | 2016-05-04 | 926 | — | $0 | 69,792 | SEC↗ |
| CREE CREE INC | A Award | 2016-04-27 | 2016-04-29 | 1,105 | $26.00 | $28.7K | 51,044 | SEC↗ |
| CREE CREE INC | A Award | 2016-01-20 | 2016-01-22 | 1,093 | $26.30 | $28.7K | 49,939 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-12-31 | 2016-01-04 | 239 | — | $0 | 68,866 | SEC↗ |
| CREE CREE INC | M Exercise deriv | 2015-12-01 | 2015-12-03 | 3,750 | — | $0 | 0 | SEC↗ |
| CREE CREE INC | M Exercise | 2015-12-01 | 2015-12-03 | 3,750 | $14.71 | $55.2K | 52,596 | SEC↗ |
| CREE CREE INC | S Sale | 2015-12-01 | 2015-12-03 | 3,750 | $27.67 | $103.8K | 48,846 | SEC↗ |
| CREE CREE INC | A Award | 2015-10-21 | 2015-10-23 | 1,199 | $23.96 | $28.7K | 48,846 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-09-30 | 2015-10-02 | 136 | — | $0 | 68,627 | SEC↗ |
| CREE CREE INC | A Award | 2015-09-01 | 2015-09-03 | 6,674 | — | $0 | 47,647 | SEC↗ |
| CREE CREE INC | A Award | 2015-08-12 | 2015-08-14 | 1,112 | $26.58 | $29.6K | 40,973 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-08-05 | 2015-08-07 | 18,750 | — | $0 | 18,750 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-06-30 | 2015-07-02 | 109 | — | $0 | 68,491 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-27 | 2015-05-27 | 1,379 | $513.39 | $708.0K | 1,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-05-22 | 2015-05-27 | 6,667 | — | $0 | 13,333 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-05-22 | 2015-05-27 | 1,607 | — | $0 | 68,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-05-22 | 2015-05-27 | 3,788 | $516.48 | $1.96M | 2,879 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-05-22 | 2015-05-27 | 6,667 | $293.53 | $1.96M | 6,667 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2015-05-15 | 2015-05-19 | 305 | — | $0 | 32,367 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2015-05-15 | 2015-05-19 | 1,521 | — | $0 | 32,062 | SEC↗ |
| CREE CREE INC | A Award | 2015-04-22 | 2015-04-24 | 811 | $32.36 | $26.2K | 39,861 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-03-31 | 2015-04-02 | 122 | — | $0 | 66,775 | SEC↗ |
| CREE CREE INC | A Award | 2015-01-21 | 2015-01-23 | 775 | $33.87 | $26.2K | 39,050 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-01-02 | 2015-01-05 | 10,838 | — | $0 | 10,838 | SEC↗ |
| CREE CREE INC | A Award | 2014-10-22 | 2014-10-24 | 962 | $27.27 | $26.2K | 38,275 | SEC↗ |
| CREE CREE INC | A Award | 2014-09-02 | 2014-09-04 | 4,244 | — | $0 | 37,313 | SEC↗ |
| CREE CREE INC | A Award | 2014-08-13 | 2014-08-15 | 390 | $44.81 | $17.5K | 33,069 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2014-07-31 | 2014-08-01 | 12,500 | $90.26 | $1.13M | 30,541 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2014-05-23 | 2014-05-28 | 2,866 | — | $0 | 66,653 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2014-05-09 | 2014-05-13 | 2,342 | — | $0 | 42,572 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2014-05-09 | 2014-05-13 | 469 | — | $0 | 43,041 | SEC↗ |
| CREE CREE INC | A Award | 2014-04-23 | 2014-04-25 | 343 | $51.01 | $17.5K | 32,679 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-04-04 | 2014-04-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CREE CREE INC | A Award | 2014-01-22 | 2014-01-24 | 222 | $67.30 | $14.9K | 32,336 | SEC↗ |
| CREE CREE INC | A Award | 2013-10-23 | 2013-10-25 | 242 | $61.75 | $14.9K | 32,114 | SEC↗ |
| CREE CREE INC | A Award deriv | 2013-09-03 | 2013-09-04 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CREE CREE INC | A Award | 2013-09-03 | 2013-09-04 | 4,000 | — | $0 | 31,872 | SEC↗ |
| CREE CREE INC | A Award | 2013-08-14 | 2013-08-16 | 255 | $58.82 | $15.0K | 27,872 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-06-04 | 2013-06-06 | 1,279 | $88.21 | $112.8K | 63,787 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer deriv | 2013-05-30 | 2013-06-03 | 1,319 | $90.81 | $119.8K | 1,281 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer | 2013-05-30 | 2013-06-03 | 127,128 | $90.81 | $11.54M | 65,066 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-05-24 | 2013-05-28 | 5,022 | — | $0 | 192,194 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2013-05-15 | 2013-05-17 | 563 | — | $0 | 40,230 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2013-05-15 | 2013-05-17 | 2,811 | — | $0 | 39,667 | SEC↗ |
| CREE CREE INC | A Award | 2013-04-24 | 2013-04-26 | 265 | $56.46 | $15.0K | 27,617 | SEC↗ |
| CREE CREE INC | A Award | 2013-01-23 | 2013-01-25 | 367 | $40.85 | $15.0K | 27,352 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-10-29 | 2012-10-31 | 22 | $91.64 | $2.0K | 8,613 | SEC↗ |
| CREE CREE INC | A Award | 2012-10-17 | 2012-10-19 | 518 | $28.92 | $15.0K | 26,985 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-10-01 | 2012-10-02 | 162 | $92.63 | $15.0K | 8,564 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-10-01 | 2012-10-02 | 27 | $92.63 | $2.5K | 8,591 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-09-24 | 2012-09-26 | 22 | $91.75 | $2.0K | 8,370 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-09-24 | 2012-09-26 | 16 | $91.75 | $1.5K | 8,402 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-09-24 | 2012-09-26 | 16 | $91.75 | $1.5K | 8,386 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-09-13 | 2012-09-26 | 5 | $89.31 | $417 | 8,348 | SEC↗ |
| CREE CREE INC | A Award deriv | 2012-09-04 | 2012-09-06 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CREE CREE INC | A Award | 2012-09-04 | 2012-09-06 | 4,000 | — | $0 | 26,467 | SEC↗ |
| CREE CREE INC | A Award | 2012-08-08 | 2012-08-10 | 553 | $27.11 | $15.0K | 22,467 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-07-31 | 2012-08-01 | 24 | $82.07 | $2.0K | 8,343 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-07-30 | 2012-08-01 | 18 | $85.30 | $1.5K | 8,301 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-07-30 | 2012-08-01 | 18 | $85.30 | $1.5K | 8,319 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-07-02 | 2012-07-03 | 26 | $94.77 | $2.5K | 8,284 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-07-02 | 2012-07-03 | 158 | $94.77 | $15.0K | 8,257 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-06-14 | 2012-07-03 | 4 | $91.64 | $405 | 8,099 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-04 | 2012-06-04 | 8,062 | — | $0 | 187,172 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer | 2012-05-30 | 2012-06-01 | 44,634 | — | $0 | 179,110 | SEC↗ |
| EW Edwards Lifesciences Corp | S Sale | 2012-05-25 | 2012-05-25 | 15,000 | $87.72 | $1.32M | 36,856 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2012-05-11 | 2012-05-14 | 473 | — | $0 | 51,856 | SEC↗ |
| EW Edwards Lifesciences Corp | A Award | 2012-05-11 | 2012-05-14 | 2,361 | — | $0 | 51,383 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-05-01 | 2012-05-02 | 21 | $96.39 | $2.0K | 8,094 | SEC↗ |
| AGN ALLERGAN INC | A Award | 2012-05-01 | 2012-05-02 | 4,800 | — | $0 | 19,382 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-04-30 | 2012-05-02 | 16 | $96.00 | $1.5K | 8,058 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-04-30 | 2012-05-02 | 16 | $96.00 | $1.5K | 8,074 | SEC↗ |
| CREE CREE INC | A Award | 2012-04-18 | 2012-04-20 | 500 | $29.97 | $15.0K | 21,914 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-04-02 | 2012-04-03 | 158 | $95.17 | $15.0K | 8,016 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-04-02 | 2012-04-03 | 26 | $95.17 | $2.5K | 8,042 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-03-16 | 2012-04-03 | 4 | $93.00 | $392 | 7,859 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-01-31 | 2012-02-01 | 23 | $87.91 | $2.0K | 7,854 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-01-30 | 2012-02-01 | 17 | $88.06 | $1.5K | 7,832 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-01-30 | 2012-02-01 | 17 | $88.06 | $1.5K | 7,815 | SEC↗ |
| CREE CREE INC | A Award | 2012-01-18 | 2012-01-20 | 613 | $24.44 | $15.0K | 21,414 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-01-03 | 2012-01-05 | 170 | $88.42 | $15.0K | 7,769 | SEC↗ |
| AGN ALLERGAN INC | A Award deriv | 2012-01-03 | 2012-01-05 | 28 | $88.42 | $2.5K | 7,798 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2011-12-31 | 2012-01-04 | 220 | — | $0 | 223,744 | SEC↗ |